Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Services - Research Services - USA
Index- P/E- EPS (ttm)-0.44 Insider Own8.86% Shs Outstand62.79M Perf Week5.26%
Market Cap37.67M Forward P/E- EPS next Y-0.21 Insider Trans- Shs Float57.23M Perf Month13.21%
Income-19.31M PEG- EPS next Q-0.06 Inst Own3.42% Short Float0.59% Perf Quarter5.26%
Sales3.77M P/S9.99 EPS this Y37.80% Inst Trans-0.92% Short Ratio2.16 Perf Half Y39.53%
Book/sh0.08 P/B7.50 EPS next Y- ROA-154.73% Target Price9.00 Perf Year-27.71%
Cash/sh0.03 P/C18.65 EPS next 5Y- ROE-225.03% 52W Range0.31 - 0.84 Perf YTD13.21%
Dividend- P/FCF- EPS past 5Y0.00% ROI-204.45% 52W High-27.98% Beta1.68
Dividend %- Quick Ratio1.06 Sales past 5Y80.67% Gross Margin- 52W Low95.16% ATR0.04
Employees20 Current Ratio1.06 Sales Q/Q438.04% Oper. Margin-522.87% RSI (14)52.57 Volatility6.15% 8.53%
OptionableNo Debt/Eq0.25 EPS Q/Q68.54% Profit Margin-511.73% Rel Volume0.74 Prev Close0.60
ShortableYes LT Debt/Eq0.10 EarningsAug 10 AMC Payout- Avg Volume155.35K Price0.61
Recom2.00 SMA200.58% SMA505.73% SMA20013.16% Volume98,991 Change0.83%
24-Apr-07Initiated Global Crown Capital Overweight $9
08-Feb-10 07:00AM  Unidym Adds Malcolm Gillis, Ph.D. to Board of Directors Business Wire
07:00AM  Arrowhead Research to Report First Quarter Fiscal 2010 Financial Results and Host Conference Call on Thursday, February 11, 2010 Business Wire
04-Feb-10 04:02PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03-Feb-10 07:00AM  InPlay: Arrowhead Research announced that Ken Myszkowski has been appointed as the Company's Chief Financial Officer Briefing.com
07:00AM  Arrowhead Appoints Chief Financial Officer Business Wire
02-Feb-10 07:00AM  Arrowhead's Portfolio Company, Nanotope, Publishes Preclinical Data Demonstrating Cartilage Regeneration Business Wire +5.26%
01-Feb-10 07:00AM  Unidym Announces Joint Venture to Market Printable CNT Electronics in Korea Business Wire
20-Jan-10 07:00AM  Unidym Completes Licensing Agreements to Expand Use of its Carbon Nanotube IP in Diverse Array of Applications Business Wire
29-Dec-09 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
09:40AM  Arrowhead Research Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript at Seeking Alpha
28-Dec-09 11:38AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
07:28AM  Amicas, Limelight: Early Volume Plays at TheStreet.com
07:00AM  Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations Business Wire
23-Dec-09 12:45PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
22-Dec-09 05:12PM  ARROWHEAD RESEARCH CORP Files SEC form 10-K, Annual Report EDGAR Online
04:30PM  Arrowhead Research Corp. Earnings Call scheduled for 4:30 pm ET today CCBN
04:01PM  Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results Business Wire
21-Dec-09 11:15AM  Arrowhead Research to Report Fiscal 2009 Fourth Quarter and Year-End Financial Results and Host Conference Call on Tuesday, December 22, 2009 Business Wire
17-Dec-09 04:49PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S EDGAR Online
04:49PM  Arrowhead Announces $3.2 Million Private Placement Business Wire
14-Dec-09 07:00AM  Arrowhead Subsidiary, Unidym, Enters into Joint Development Agreement with a Major Liquid Crystal Display (LCD) Manufacturer for Glass Based Liquid Crystal Displays Business Wire
02-Dec-09 07:00AM  Unidym and Nano-C Enter Exclusive License Agreement for Fullerene Derivatives Used in Solar Cells Business Wire
11-Nov-09 07:00AM  Arrowhead Subsidiary Unidym, Inc. Enters into Third Year of Joint Development Program with Samsung Electronics for Flexible Displays Business Wire +9.68%
04-Nov-09 07:00AM  Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors Business Wire
03-Nov-09 07:00AM  Arrowhead CEO Provides Update on Company Strategy and Operations Business Wire +7.41%
06-Oct-09 04:04PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princi EDGAR Online
21-Sep-09 04:09PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online
18-Sep-09 07:00PM  Arrowhead Receives NASDAQ Deficiency Notice Related to Minimum Bid Price Business Wire +9.43%
15-Sep-09 01:34PM  Arrowhead Research Corp. CEO and President Interview: Christopher Anzalone Wall Street Transcript +24.56%
19-Aug-09 06:50AM  Beacon Equity Issues Trading Outlook for New Energy Technologies Inc. GlobeNewswire
12-Aug-09 07:00AM  Arrowhead Regains Compliance with NASDAQ Listing Requirements Business Wire
10-Aug-09 04:30PM  Arrowhead Research Corp. Earnings Call scheduled for 4:30 pm ET today CCBN
04:02PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Notice of Delisting or Fai EDGAR Online
04:01PM  Arrowhead Reports Third Quarter Fiscal 2009 Financial Results Business Wire
07:07AM  Q3 2009 Arrowhead Research Corp. Earnings Release - After Market Close CCBN
07-Aug-09 07:00AM  Arrowhead Announces Completion of $2.76 Million Private Placement Business Wire
05-Aug-09 05:06PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04-Aug-09 07:00AM  Arrowhead Research to Report Fiscal Third Quarter 2009 Financial Results and Host Conference Call on Monday, August 10 2009 Business Wire
30-Jul-09 04:00PM  Arrowhead Senior Advisors Featured in Nature and Nature Medicine Articles Business Wire
21-Jul-09 05:14PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online +6.25%
17-Jul-09 05:07PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
16-Jul-09 07:00AM  Arrowhead Increases Ownership in Carbon Nanotube-based Electronics Films Subsidiary Unidym Inc. to 70% Business Wire
10-Jul-09 08:43AM  Arrowhead Announces Private Placement of $2 Million Business Wire +5.71%
08:40AM  Arrowhead Announces CFO Transition Business Wire
09-Jul-09 04:32PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
29-Jun-09 04:27PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S EDGAR Online -6.38%
23-Jun-09 04:01PM  Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation Business Wire
04:01PM  Arrowhead Subsidiary Calando Pharmaceuticals Enters into License Agreement with Cerulean Pharma Inc. Business Wire
27-May-09 04:26PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online -6.56%
04:01PM  Arrowhead Receives and Responds to Notification of Minimum Stockholders' Equity Non-Compliance from the NASDAQ Stock Market Business Wire
15-May-09 09:16AM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online -10.91%
09:00AM  Arrowhead Research Corp. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q2 2009 Arrowhead Research Corp. Earnings Release - Before Market Open CCBN
07:00AM  Arrowhead Reports Second Quarter Fiscal 2009 Financial Results Business Wire
13-May-09 04:53PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -9.38%
11-May-09 07:30AM  Arrowhead Subsidiary Unidym Establishes Partnership with Continental Carbon Company Business Wire
07:00AM  Arrowhead Research Corporation to Report Second Quarter 2009 Financial Results and Host Conference Call on Friday, May 15th Business Wire
29-Apr-09 09:44AM  Arrowhead Scientific Advisory Board Member Appointed to the President's Council of Advisors on Science and Technology Business Wire -6.35%
06-Apr-09 07:00AM  Arrowhead Increases Stake in Majority-Owned Subsidiary Unidym, Inc., a Leader in Carbon Nanotube Technology Business Wire
03-Apr-09 04:30PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State EDGAR Online -11.43%
26-Mar-09 12:09PM  CORRECTING and REPLACING Reminder: Arrowhead to Hold 2009 Annual Meeting of Shareholders Today, Thursday, March 26, 2009 Business Wire +6.52%
18-Mar-09 04:35PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:01AM  Arrowhead Provides Comments on Recently-Filed Proxy Statement Business Wire
07:00AM  Arrowhead Management to Present Objectives for 2009 Via Webcast Following Annual Meeting of Shareholders on Thursday, March 26, 2009 Business Wire
09-Mar-09 04:55PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online +23.26%
06-Mar-09 07:00AM  Arrowhead to Transfer to The NASDAQ Capital Market Business Wire +19.44%
27-Feb-09 04:14PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
18-Feb-09 08:31AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online
07:00AM  Arrowhead CEO Comments on Recent Nasdaq Letter Business Wire
13-Feb-09 05:23PM  Arrowhead Receives Notification of Minimum Stockholders' Equity Non-Compliance from the Nasdaq Stock Market Business Wire
09-Feb-09 10:12PM  Arrowhead Research Corporation Q1 2009 Earnings Call Transcript at Seeking Alpha
05:00PM  Arrowhead Research Corp. Earnings Call scheduled for 5:00 pm ET today CCBN
04:26PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead Reports First Quarter Fiscal 2009 Financial Results Business Wire
07:07AM  Q1 2009 ARROWHEAD RESH CORP Earnings Release - Time Not Supplied CCBN
03-Feb-09 07:00AM  Arrowhead Research Corporation to Report Fiscal First Quarter 2009 Financial Results and Host Conference Call on Monday, February 9th Business Wire
26-Jan-09 07:00AM  Arrowheads Majority Owned Subsidiary, Unidym, Inc. Consolidates Operations Business Wire
23-Jan-09 04:12PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities EDGAR Online
05-Jan-09 08:08AM  Energy Edge: Carbon Chicken Wire at BusinessWeek +11.43%
30-Dec-08 02:43PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
22-Dec-08 07:00PM  CORRECTING and REPLACING Arrowhead Reports Fourth Quarter and Full Year 2008 Financial Results Business Wire -7.50%
19-Dec-08 09:04AM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
15-Dec-08 10:50PM  Arrowhead Research Corporation F4Q08 (Qtr End 09/30/08) Earnings Call Transcript at Seeking Alpha +10.53%
05:22PM  ARROWHEAD RESEARCH CORP Files SEC form 10-K, Annual Report EDGAR Online
05:00PM  ARROWHEAD RESH CORP Earnings Call scheduled for 5:00 pm ET today CCBN
04:01PM  Arrowhead Reports Fourth Quarter and Full Year 2008 Financial Results Business Wire
07:07AM  Q4 2008 ARROWHEAD RESH CORP Earnings Release - Time Not Supplied CCBN
09-Dec-08 07:00AM  Arrowhead to Announce Fourth Quarter and Full Year 2008 Financial Results and Host Conference Call Business Wire
08-Dec-08 07:00AM  Calando Pharmaceuticals Publishes New Results of siRNA Delivery Using Its RONDEL Technology in Sepsis Business Wire +7.30%
03-Dec-08 04:52PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
07:01AM  Arrowhead Raises $5.4 Million into Two Subsidiaries; Initiatives Strengthen Balance Sheet for 2009 Business Wire
07:00AM  TEL Venture Capital, Inc. Invests Additional Capital into Unidym, Plans Collaboration in LCD and Solar Industries Business Wire
28-Nov-08 04:05PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online -8.57%
19-Nov-08 04:40PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
07:00AM  Arrowhead CEO Provides Update on Tego Biosciences Corporation Business Wire
17-Nov-08 07:00AM  Arrowhead Research Corporation Retains The Piacente Group, Inc. as Strategic Investor Relations Consulting Firm Business Wire +12.14%
12-Nov-08 07:00AM  Arrowhead CEO Provides Update on Nanotope, Inc. Business Wire
10-Nov-08 05:11PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -8.57%
04-Nov-08 07:00AM  Arrowhead CEO Provides Update on Majority Owned Subsidiary Unidym, Inc. Business Wire
03-Nov-08 07:00AM  Calando Pharmaceuticals to Present at 19th Annual Oppenheimer Healthcare Conference on November 4, 2008 Business Wire +15.83%
Arrowhead Research Corporation, through its subsidiaries, identifies advances in nanotechnology and matches them with product development opportunities in high-growth markets, focusing on the electronics and biotech industries. It focuses on developing, commercializing, and licensing a range of nanotechnology products and applications, including anti-cancer drugs, RNAi therapeutics, regenerative therapeutics, advanced drug delivery technology, energy storage technology, carbon-based electronics, and fullerene anti-oxidants. The company has developed Cyclosert, a proprietary drug delivery platform technology based on a nano-engineered class of linear cyclodextrin-containing polymers. Its lead anti-cancer drug candidate IT-101 is a combination of Cyclosert and the potent anti-cancer drug, camptothecin, is under Phase I clinical trials. Arrowhead Research also focuses on the design, development, and commercialization of novel RNA interference (RNAi) therapeutics to treat diseases and other medical conditions by combining RNAi therapeutics with patented and proprietary delivery technologies. Its CALAA-01 product is a formulation of proprietary delivery technology with a siRNA duplex targeting the M2 subunit of ribonucleotide reductase. In addition, the company engages in the manufacture and application of carbon nanotubes-based products for the electronics industry. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.